[1]
A. Pisula, A. Sienicka, A. Dobrowolska-Redo, J. Kacperczyk-Bartnik, and E. Romejko-Wolniewicz, “PARP inhibitors in ovarian cancer therapy”, Prosp. Pharm. Sc., vol. 22, no. 2, pp. 71–74, Jun. 2024.